PYRROLIDINE DITHIOCARBAMATE INHIBITS THE PRODUCTION OF INTERLEUKIN-6,INTERLEUKIN-8, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BY HUMAN ENDOTHELIAL-CELLS IN RESPONSE TO INFLAMMATORY MEDIATORS - MODULATION OF NF-KAPPA-B AND AP-1 TRANSCRIPTION FACTORS ACTIVITY
C. Munoz et al., PYRROLIDINE DITHIOCARBAMATE INHIBITS THE PRODUCTION OF INTERLEUKIN-6,INTERLEUKIN-8, AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BY HUMAN ENDOTHELIAL-CELLS IN RESPONSE TO INFLAMMATORY MEDIATORS - MODULATION OF NF-KAPPA-B AND AP-1 TRANSCRIPTION FACTORS ACTIVITY, Blood, 88(9), 1996, pp. 3482-3490
Endothelial cells (EC) play a key role in the inflammatory response, b
oth by the production of proinflammatory cytokines and by their intera
ction with leukocytes. Molecular genetic analysis has demonstrated tha
t functional NF-kappa B sites are involved in the transcription of int
erleukin-6 (IL-6), IL-8, and granulocyte-macrophage colony-stimulating
factor (GM-CSF) genes in response to inflammatory mediators, Thus, we
have explored the effect of two inhibitors of the NF-kappa B activati
on, pyrrolidine dithiocarbamate (PDTC) and N-acetylcysteine (NAC), on
the production of these cytokines by EC. Both PDTC and NAC inhibited,
in a dose-dependent manner, the synthesis of IL-6, IL-8, and GM-CSF in
duced by tumor necrosis factor (TNF)-alpha or bacterial lipopolysaccha
rides (LPS) in human umbilical vein endothelial cells (HUVEC). PDTC ap
peared to prevent IL-6, IL-8, and GM-CSF gene transcription, as it blo
cked the induction of specific mRNA by TNF-alpha or LPS. The TNF-alpha
-mediated transcriptional activation of a chloramphenicol acetyltransf
erase (CAT) plasmid containing three copies of the -72 kappa B binding
site from the IL-6 promoter was abrogated by PDTC. According to trans
fection experiments, electrophoretic mobility shift assays (EMSA) demo
nstrated that the antioxidant prevented the induction of NF-kappa B DN
A-binding activity by TNF-alpha. Under the same conditions, PDTC by it
self or in combination with TNF-alpha, enhanced the DNA-binding activi
ty of AP-1, as well as c-fos and c-jun mRNA levels, Altogether, these
results indicate that the antioxidant PDTC specifically inhibits the t
ranscription of IL-6, IL-8, and GM-CSF genes through the inhibition of
the NF-kappa B activation, while increasing the expression of AP-1. O
ur data make evident the antiinflammatory and immunoregulatory potenti
al of the pharmacological inhibition of the NF-kappa B activation. In
addition, PDTC and related molecules may be a useful tool to explore t
he expression of genes involved in the inflammatory response. (C) 1996
by The American Society of Hematology.